Federico Almonacid‐Cardenas
Papers
1
Total Citations
6
H-Index
1
About
Federico Almonacid‐Cardenas is an anesthesiology researcher whose work focuses on regional anesthesia techniques for cardiac surgery, particularly in the context of enhanced recovery after surgery (ERAS) protocols. His major contributions center on evaluating the safety and efficacy of novel fascial plane blocks—such as the pecto-serratus and serratus anterior plane injections—in robotically-assisted mitral valve procedures. His landmark 2024 sub-study of a randomized trial, which measured blood bupivacaine concentrations after administration of both plain and liposomal formulations, has garnered 6 citations and provides critical pharmacokinetic data to guide clinical practice. This work addresses a key gap in understanding local anesthetic systemic toxicity risks during minimally invasive cardiac surgeries. Almonacid‐Cardenas’s research is notable for bridging the gap between innovative block techniques and patient safety, offering evidence that supports the integration of multimodal analgesia in high-risk surgical populations. His findings are increasingly referenced by clinicians seeking to optimize pain management while minimizing opioid-related complications, marking him as an emerging voice in perioperative medicine.
Research Focus
Key Achievements
Top Papers
- 1